195 related articles for article (PubMed ID: 22197620)
1. Intussusceptive microvascular growth in tumors.
Ribatti D; Djonov V
Cancer Lett; 2012 Mar; 316(2):126-31. PubMed ID: 22197620
[TBL] [Abstract][Full Text] [Related]
2. Vascular remodeling by intussusceptive angiogenesis.
Djonov V; Baum O; Burri PH
Cell Tissue Res; 2003 Oct; 314(1):107-17. PubMed ID: 14574551
[TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
4. Microvascular growth, development, and remodeling in the embryonic avian kidney: the interplay between sprouting and intussusceptive angiogenic mechanisms.
Makanya AN; Stauffer D; Ribatti D; Burri PH; Djonov V
Microsc Res Tech; 2005 Apr; 66(6):275-88. PubMed ID: 16003781
[TBL] [Abstract][Full Text] [Related]
5. Microvascular density, vascular endothelial growth factor immunoreactivity in tumor cells, vessel diameter and intussusceptive microvascular growth in primary melanoma.
Ribatti D; Nico B; Floris C; Mangieri D; Piras F; Ennas MG; Vacca A; Sirigu P
Oncol Rep; 2005 Jul; 14(1):81-4. PubMed ID: 15944771
[TBL] [Abstract][Full Text] [Related]
6. Intussusceptive angiogenesis: a biologically relevant form of angiogenesis.
De Spiegelaere W; Casteleyn C; Van den Broeck W; Plendl J; Bahramsoltani M; Simoens P; Djonov V; Cornillie P
J Vasc Res; 2012; 49(5):390-404. PubMed ID: 22739226
[TBL] [Abstract][Full Text] [Related]
7. Escape mechanisms after antiangiogenic treatment, or why are the tumors growing again?
Hlushchuk R; Makanya AN; Djonov V
Int J Dev Biol; 2011; 55(4-5):563-7. PubMed ID: 21858777
[TBL] [Abstract][Full Text] [Related]
8. Intussusceptive microvascular growth in human glioma.
Nico B; Crivellato E; Guidolin D; Annese T; Longo V; Finato N; Vacca A; Ribatti D
Clin Exp Med; 2010 Jun; 10(2):93-8. PubMed ID: 19882213
[TBL] [Abstract][Full Text] [Related]
9. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ
Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784
[TBL] [Abstract][Full Text] [Related]
10. Blood and lymph vessels in embryonic tumors.
Rössler J; Lagodny J
Hematol Oncol; 2005; 23(3-4):94-101. PubMed ID: 16267811
[TBL] [Abstract][Full Text] [Related]
11. Intussusceptive angiogenesis: its emergence, its characteristics, and its significance.
Burri PH; Hlushchuk R; Djonov V
Dev Dyn; 2004 Nov; 231(3):474-88. PubMed ID: 15376313
[TBL] [Abstract][Full Text] [Related]
12. Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer.
Langenkamp E; Molema G
Cell Tissue Res; 2009 Jan; 335(1):205-22. PubMed ID: 18677515
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis and prostate cancer tumor growth.
Nicholson B; Theodorescu D
J Cell Biochem; 2004 Jan; 91(1):125-50. PubMed ID: 14689586
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor (VEGF) signaling in tumor progression.
Roskoski R
Crit Rev Oncol Hematol; 2007 Jun; 62(3):179-213. PubMed ID: 17324579
[TBL] [Abstract][Full Text] [Related]
15. The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review.
Ribatti D
Br J Haematol; 2005 Feb; 128(3):303-9. PubMed ID: 15667531
[TBL] [Abstract][Full Text] [Related]
16. [Significance of vascular endothelial growth factor--VEGF--in tumor angiogenesis. Therapeutic possibilities in solid tumors].
Werther K; Nielsen HJ
Ugeskr Laeger; 2000 Sep; 162(37):4916-20. PubMed ID: 11002739
[No Abstract] [Full Text] [Related]
17. [The mechanism of tumor angiogenesis].
Ravaud A
Prog Urol; 2007 Feb; 17(1 Suppl 1):144-7. PubMed ID: 17571638
[No Abstract] [Full Text] [Related]
18. Vernolide-A inhibits tumour specific angiogenesis by regulating proinflammatory cytokines, VEGF, MMPs and TIMP.
Pratheeshkumar P; Kuttan G
Eur J Pharmacol; 2011 Apr; 656(1-3):10-8. PubMed ID: 21256125
[TBL] [Abstract][Full Text] [Related]
19. VEGF inhibition: insights from preclinical and clinical studies.
Crawford Y; Ferrara N
Cell Tissue Res; 2009 Jan; 335(1):261-9. PubMed ID: 18766380
[TBL] [Abstract][Full Text] [Related]
20. Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications.
De Bock K; Cauwenberghs S; Carmeliet P
Curr Opin Genet Dev; 2011 Feb; 21(1):73-9. PubMed ID: 21106363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
